glp-1 nmda agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice glp-1_ra_pharmacology [TUSOM | Pharmwiki]
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
![glp-1 nmda agonist Liraglutide prevents MK801induced schizophrenialike behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice glp-1_ra_pharmacology [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1_cellular_moa.png)
![glp-1 nmda agonist Liraglutide prevents MK801induced schizophrenialike behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice glp-1_ra_pharmacology [TUSOM | Pharmwiki]](https://www.invivogen.com/sites/default/files/styles/wide/public/invivogen/media/image/4%20-%20GLP1%20ligand.png?itok=b7aSrKqV)
![glp-1 nmda agonist Liraglutide prevents MK801induced schizophrenialike behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice glp-1_ra_pharmacology [TUSOM | Pharmwiki]](https://www.mdpi.com/jcm/jcm-13-04674/article_deploy/html/images/jcm-13-04674-g001.png)
![glp-1 nmda agonist Liraglutide prevents MK801induced schizophrenialike behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice glp-1_ra_pharmacology [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639d/10230051/9f6352454904/fimmu-14-1148209-g010.jpg)




















